Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

Here's How Much You Would Have Made Owning Halozyme Therapeutics Stock In The Last 15 Years

Upworthy

Published

Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 4.64% on an annualized basis producing an average annual return of 15.92%. Currently, Halozyme Therapeutics has a market capitalization of $8.38 billion. Buying $100 In HALO: If ... Full story available on…

Full Article